Equifax Other Income (Expense) increased by 35.7% to $3.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 52.0%, from $2.50M to $3.80M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a -27.3% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.00M | $27.20M | -$75.50M | $11.10M | $1.80M | $23.90M | $19.90M | $4.40M | $15.90M | $7.10M | $0.00 | $1.60M | -$300.00K | $3.00M | -$6.80M | $2.50M | $3.60M | $3.20M | $2.80M | $3.80M |
| QoQ Change | — | +353.3% | -377.6% | +114.7% | -83.8% | >999% | -16.7% | -77.9% | +261.4% | -55.3% | -100.0% | — | -118.8% | >999% | -326.7% | +136.8% | +44.0% | -11.1% | -12.5% | +35.7% |
| YoY Change | — | — | — | — | -70.0% | -12.1% | +126.4% | -60.4% | +783.3% | -70.3% | -100.0% | -63.6% | -101.9% | -57.7% | — | +56.3% | >999% | +6.7% | +141.2% | +52.0% |